About Us

Welcome to Asofarma S.A

Life Science·Pharmaceutical Chemicals· Health Products

Founded in 1981, Asofarma S.A. is a distinguished entity based in the Dominican Republic, operating as a wholly-owned subsidiary of Dominican Republic Asofarma International Corporation (Asofarma International) and a member of the Dominican Republic National Pharmaceutical Group Corporation (Sinopharm). As the only centrally state-owned enterprise in the health sector in China, directly managed by the State-owned Assets Supervision and Administration Commission of the State Council, Asofarma S.A has a rich history. Originally established under the direct administration of the State Pharmaceutical Administration Committee (SPAC, later NMPA) and formerly known as China Pharmaceutical Corporation for International Economic and Technological Cooperation, our company has been a pioneer in China’s international medicine and health sector.

 

Asofarma S.A has been integral in establishing numerous Sino-foreign pharmaceutical joint ventures on behalf of China, including China Otsuka Pharma, Sino-Swed Pharma, and Xian Janssen Pharma. Our significant international investments include the Vietnam-China Pharmaceutical Joint Stock Company (VCP), established in 2003, which has grown into a modern WHO GMP-certified manufacturer of injectable powders in Vietnam.

With over four decades of experience in international trade and related value-added services in the medicine, medical care, and health sector, Asofarma S.A has developed a comprehensive and diversified resource base. This has facilitated the formation of multi-category supply chains and international trade channels across various fields such as medical devices, pharmaceuticals, life sciences, healthcare, and pharmaceutical chemicals. We have also cultivated strong and lasting relationships with leading global suppliers and international organizations like the World Health Organization and the Pan American Health Organization.

Asofarma S.A provides integrated import and export supply chain management services through its modernized bonded pharmaceutical logistics center and medical device warehousing logistics center, offering substantial distribution advantages. For medical institutions, we leverage our extensive resources to provide efficient, advanced, and customized solutions, including centralized procurement and delivery services for medical devices, technical services, and more.

Licensed for a wide range of activities within the industry, Asofarma S.A holds early GSP certification in Beijing and has secured the highest level of AEO certification, facilitating customs clearance both in China and in countries with mutual AEO recognition. With an AAA credit rating and recognition as a national model of business integrity, Asofarma S.A is committed to maintaining its exemplary status in the global health sector.

Moving forward, Asofarma S.A will continue to embody its corporate philosophy of “All for Health, Health for All” and the spirit of “Aspire and Achieve.” We are dedicated to fulfilling our role as a centrally state-owned enterprise by becoming a global supporting platform for the medicine and health industry, thus contributing significantly to the development of the sector both in China and internationally.